EP1169027A4 - Arthrosebehandlung - Google Patents

Arthrosebehandlung

Info

Publication number
EP1169027A4
EP1169027A4 EP00918058A EP00918058A EP1169027A4 EP 1169027 A4 EP1169027 A4 EP 1169027A4 EP 00918058 A EP00918058 A EP 00918058A EP 00918058 A EP00918058 A EP 00918058A EP 1169027 A4 EP1169027 A4 EP 1169027A4
Authority
EP
European Patent Office
Prior art keywords
osteoarthritis
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00918058A
Other languages
English (en)
French (fr)
Other versions
EP1169027A1 (de
Inventor
Carl M Mendel
Timothy B Seaton
Steve P Weinstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Abbott GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott GmbH and Co KG filed Critical Abbott GmbH and Co KG
Publication of EP1169027A1 publication Critical patent/EP1169027A1/de
Publication of EP1169027A4 publication Critical patent/EP1169027A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EP00918058A 1999-03-19 2000-03-17 Arthrosebehandlung Withdrawn EP1169027A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12530099P 1999-03-19 1999-03-19
US125300P 1999-03-19
PCT/US2000/007072 WO2000056306A1 (en) 1999-03-19 2000-03-17 Treatment of osteoarthritis

Publications (2)

Publication Number Publication Date
EP1169027A1 EP1169027A1 (de) 2002-01-09
EP1169027A4 true EP1169027A4 (de) 2004-10-20

Family

ID=22419072

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00918058A Withdrawn EP1169027A4 (de) 1999-03-19 2000-03-17 Arthrosebehandlung

Country Status (20)

Country Link
EP (1) EP1169027A4 (de)
JP (2) JP2002539248A (de)
KR (1) KR20020038567A (de)
CN (1) CN1352552A (de)
AU (1) AU773490B2 (de)
BG (1) BG105999A (de)
BR (1) BR0009081A (de)
CA (1) CA2366660A1 (de)
CZ (1) CZ20013284A3 (de)
HK (1) HK1044702A1 (de)
HU (1) HUP0200494A2 (de)
IL (1) IL145238A0 (de)
MX (1) MXPA01009461A (de)
NO (1) NO20014477L (de)
NZ (1) NZ514016A (de)
PL (1) PL365463A1 (de)
SK (1) SK13342001A3 (de)
TR (1) TR200102699T2 (de)
WO (1) WO2000056306A1 (de)
ZA (1) ZA200107682B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476078B2 (en) 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US6974838B2 (en) 1998-08-24 2005-12-13 Sepracor Inc. Methods of treating or preventing pain using sibutramine metabolites
US6399826B1 (en) 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
WO2002083631A1 (en) 2001-04-13 2002-10-24 Sepracor Inc. Methods of preparing didesmethylsibutramine and other sibutramine derivatives

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998013033A1 (en) * 1996-09-25 1998-04-02 Knoll Aktiengesellschaft Medical treatment

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA821577B (en) * 1981-04-06 1983-03-30 Boots Co Plc Therapeutic agents
ZA836848B (en) * 1982-09-30 1984-05-30 Boots Co Plc Therapeutic agents
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
JP2675573B2 (ja) * 1988-03-31 1997-11-12 科研製薬株式会社 脳機能改善剤
IE61928B1 (en) * 1988-11-29 1994-11-30 Boots Co Plc Treatment of obesity
WO1994000047A1 (en) * 1992-06-23 1994-01-06 Sepracor Inc. Methods and compositions for treating depression and other disorders using optically pure (+) sibutramine
AU4542893A (en) * 1992-06-23 1994-01-24 Sepracor, Inc. Methods and compositions for treating depression and other disorders using optically pure (-) sibutramine
JP3862295B2 (ja) * 1993-09-30 2006-12-27 独立行政法人理化学研究所 抗肥満剤
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment
EP0763016B1 (de) * 1994-06-01 2000-01-26 Axys Pharmaceuticals, Inc. Zusammensetzungen und verfahren zur behandlung von durch mast-zellen verursachten krankheiten
MA24500A1 (fr) * 1997-03-21 1998-10-01 Lg Life Sciences Ltd Derive du sel d'acide carboxylique de naphthyridine .

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998013033A1 (en) * 1996-09-25 1998-04-02 Knoll Aktiengesellschaft Medical treatment

Also Published As

Publication number Publication date
CZ20013284A3 (cs) 2002-10-16
HK1044702A1 (zh) 2002-11-01
AU773490B2 (en) 2004-05-27
NO20014477L (no) 2001-11-01
HUP0200494A2 (en) 2002-08-28
PL365463A1 (en) 2005-01-10
NO20014477D0 (no) 2001-09-14
ZA200107682B (en) 2003-06-18
TR200102699T2 (tr) 2002-03-21
IL145238A0 (en) 2002-06-30
CA2366660A1 (en) 2000-09-28
KR20020038567A (ko) 2002-05-23
JP2012051904A (ja) 2012-03-15
AU3893200A (en) 2000-10-09
EP1169027A1 (de) 2002-01-09
WO2000056306A1 (en) 2000-09-28
BG105999A (en) 2002-06-28
SK13342001A3 (sk) 2002-04-04
JP2002539248A (ja) 2002-11-19
NZ514016A (en) 2001-09-28
MXPA01009461A (es) 2004-03-19
BR0009081A (pt) 2003-03-05
CN1352552A (zh) 2002-06-05

Similar Documents

Publication Publication Date Title
HK1161893A1 (zh) 煤炭加工
GB2351661B (en) Novel method of treatment
IL145875A0 (en) Novel method of treatment
GB9925136D0 (en) Novel treatment
PL349347A1 (en) Novel treatment
AU3896900A (en) Treatment of pain
NZ513686A (en) Treatment of trauma
GB9924087D0 (en) Treatment of process fluids
IL145238A0 (en) Treatment of osteoarthritis
IL149281A0 (en) Treatment of cancer
GB9930688D0 (en) Novel method of treatment
GB0205263D0 (en) Treatment of chemical hydrolysates
HUP0203741A3 (en) Treatment of osteoporosis
NZ514013A (en) Treatment of hiatial hernia
GB9911183D0 (en) Treatment of cancers
GB9930696D0 (en) Novel method of treatment
GB9901310D0 (en) Methods of treatment
GB9917181D0 (en) Methods of treatment
EP1165060A4 (de) Behandlung von gallensteinen
GB9918534D0 (en) Treatment of cancers
GB9911346D0 (en) Treatment of cancers
GB9927005D0 (en) Treatment of cancers
GB9930690D0 (en) Novel method of treatment
GB0122638D0 (en) Novel method of treatment
GB9930689D0 (en) Novel method of treatment

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010919

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: LT PAYMENT 20010919;LV PAYMENT 20010919;RO PAYMENT 20010919;SI PAYMENT 20010919

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: ABBOTT GMBH & CO. KG

A4 Supplementary search report drawn up and despatched

Effective date: 20040902

17Q First examination report despatched

Effective date: 20061002

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/135 20060101AFI20080811BHEP

Ipc: A61P 19/02 20060101ALI20080811BHEP

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1044702

Country of ref document: HK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20081001